Global Enasidenib Drugs Market Research Report 2026(Status and Outlook)
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic testEnasidenib is a targeted therapy used to treat relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. Its efficacy in inhibiting the mutated IDH2 enzyme and inducing remission has driven market growth. The limited treatment options for this specific subset of AML contribute to its niche status. However, challenges include potential side effects and the need for genetic testing to identify eligible patients. The market competition is relatively small, as Enasidenib remains a targeted therapy for a specific AML subgroup. Despite challenges, the Enasidenib market offers potential for growth as healthcare providers seek effective treatments for patients with IDH2-mutated AML. Continued research and clinical advancements can further drive market expansion.
The global Enasidenib Drugs market size was estimated at USD 88.7 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Enasidenib Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Enasidenib Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Enasidenib Drugs market.
Global Enasidenib Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bristol Myers Squibb
Market Segmentation (by Type)
50mg
100mg
Market Segmentation (by Application)
Hospital
Pharmacy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Enasidenib Drugs Market
Overview of the regional outlook of the Enasidenib Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Enasidenib Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Enasidenib Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Enasidenib Drugs market size was estimated at USD 88.7 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Enasidenib Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Enasidenib Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Enasidenib Drugs market.
Global Enasidenib Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bristol Myers Squibb
Market Segmentation (by Type)
50mg
100mg
Market Segmentation (by Application)
Hospital
Pharmacy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Enasidenib Drugs Market
Overview of the regional outlook of the Enasidenib Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Enasidenib Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Enasidenib Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Enasidenib Drugs
1.2 Key Market Segments
1.2.1 Enasidenib Drugs Segment by Type
1.2.2 Enasidenib Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ENASIDENIB DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Enasidenib Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Enasidenib Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ENASIDENIB DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Enasidenib Drugs Product Life Cycle
3.3 Global Enasidenib Drugs Sales by Manufacturers (2020-2025)
3.4 Global Enasidenib Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Enasidenib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Enasidenib Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Enasidenib Drugs Market Competitive Situation and Trends
3.8.1 Enasidenib Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Enasidenib Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ENASIDENIB DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Enasidenib Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ENASIDENIB DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Enasidenib Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Enasidenib Drugs Market
5.7 ESG Ratings of Leading Companies
6 ENASIDENIB DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Enasidenib Drugs Sales Market Share by Type (2020-2025)
6.3 Global Enasidenib Drugs Market Size by Type (2020-2025)
6.4 Global Enasidenib Drugs Price by Type (2020-2025)
7 ENASIDENIB DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Enasidenib Drugs Market Sales by Application (2020-2025)
7.3 Global Enasidenib Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Enasidenib Drugs Sales Growth Rate by Application (2020-2025)
8 ENASIDENIB DRUGS MARKET SALES BY REGION
8.1 Global Enasidenib Drugs Sales by Region
8.1.1 Global Enasidenib Drugs Sales by Region
8.1.2 Global Enasidenib Drugs Sales Market Share by Region
8.2 Global Enasidenib Drugs Market Size by Region
8.2.1 Global Enasidenib Drugs Market Size by Region
8.2.2 Global Enasidenib Drugs Market Size by Region
8.3 North America
8.3.1 North America Enasidenib Drugs Sales by Country
8.3.2 North America Enasidenib Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Enasidenib Drugs Sales by Country
8.4.2 Europe Enasidenib Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Enasidenib Drugs Sales by Region
8.5.2 Asia Pacific Enasidenib Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Enasidenib Drugs Sales by Country
8.6.2 South America Enasidenib Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Enasidenib Drugs Sales by Region
8.7.2 Middle East and Africa Enasidenib Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ENASIDENIB DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Enasidenib Drugs by Region(2020-2025)
9.2 Global Enasidenib Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Enasidenib Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Enasidenib Drugs Production
9.4.1 North America Enasidenib Drugs Production Growth Rate (2020-2025)
9.4.2 North America Enasidenib Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Enasidenib Drugs Production
9.5.1 Europe Enasidenib Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Enasidenib Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Enasidenib Drugs Production (2020-2025)
9.6.1 Japan Enasidenib Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Enasidenib Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Enasidenib Drugs Production (2020-2025)
9.7.1 China Enasidenib Drugs Production Growth Rate (2020-2025)
9.7.2 China Enasidenib Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bristol Myers Squibb
10.1.1 Bristol Myers Squibb Basic Information
10.1.2 Bristol Myers Squibb Enasidenib Drugs Product Overview
10.1.3 Bristol Myers Squibb Enasidenib Drugs Product Market Performance
10.1.4 Bristol Myers Squibb Business Overview
10.1.5 Bristol Myers Squibb SWOT Analysis
10.1.6 Bristol Myers Squibb Recent Developments
11 ENASIDENIB DRUGS MARKET FORECAST BY REGION
11.1 Global Enasidenib Drugs Market Size Forecast
11.2 Global Enasidenib Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Enasidenib Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Enasidenib Drugs Market Size Forecast by Region
11.2.4 South America Enasidenib Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Enasidenib Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Enasidenib Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Enasidenib Drugs by Type (2026-2035)
12.1.2 Global Enasidenib Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Enasidenib Drugs by Type (2026-2035)
12.2 Global Enasidenib Drugs Market Forecast by Application (2026-2035)
12.2.1 Global Enasidenib Drugs Sales (K MT) Forecast by Application
12.2.2 Global Enasidenib Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Enasidenib Drugs
1.2 Key Market Segments
1.2.1 Enasidenib Drugs Segment by Type
1.2.2 Enasidenib Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ENASIDENIB DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Enasidenib Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Enasidenib Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ENASIDENIB DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Enasidenib Drugs Product Life Cycle
3.3 Global Enasidenib Drugs Sales by Manufacturers (2020-2025)
3.4 Global Enasidenib Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Enasidenib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Enasidenib Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Enasidenib Drugs Market Competitive Situation and Trends
3.8.1 Enasidenib Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Enasidenib Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ENASIDENIB DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Enasidenib Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ENASIDENIB DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Enasidenib Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Enasidenib Drugs Market
5.7 ESG Ratings of Leading Companies
6 ENASIDENIB DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Enasidenib Drugs Sales Market Share by Type (2020-2025)
6.3 Global Enasidenib Drugs Market Size by Type (2020-2025)
6.4 Global Enasidenib Drugs Price by Type (2020-2025)
7 ENASIDENIB DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Enasidenib Drugs Market Sales by Application (2020-2025)
7.3 Global Enasidenib Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Enasidenib Drugs Sales Growth Rate by Application (2020-2025)
8 ENASIDENIB DRUGS MARKET SALES BY REGION
8.1 Global Enasidenib Drugs Sales by Region
8.1.1 Global Enasidenib Drugs Sales by Region
8.1.2 Global Enasidenib Drugs Sales Market Share by Region
8.2 Global Enasidenib Drugs Market Size by Region
8.2.1 Global Enasidenib Drugs Market Size by Region
8.2.2 Global Enasidenib Drugs Market Size by Region
8.3 North America
8.3.1 North America Enasidenib Drugs Sales by Country
8.3.2 North America Enasidenib Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Enasidenib Drugs Sales by Country
8.4.2 Europe Enasidenib Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Enasidenib Drugs Sales by Region
8.5.2 Asia Pacific Enasidenib Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Enasidenib Drugs Sales by Country
8.6.2 South America Enasidenib Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Enasidenib Drugs Sales by Region
8.7.2 Middle East and Africa Enasidenib Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ENASIDENIB DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Enasidenib Drugs by Region(2020-2025)
9.2 Global Enasidenib Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Enasidenib Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Enasidenib Drugs Production
9.4.1 North America Enasidenib Drugs Production Growth Rate (2020-2025)
9.4.2 North America Enasidenib Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Enasidenib Drugs Production
9.5.1 Europe Enasidenib Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Enasidenib Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Enasidenib Drugs Production (2020-2025)
9.6.1 Japan Enasidenib Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Enasidenib Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Enasidenib Drugs Production (2020-2025)
9.7.1 China Enasidenib Drugs Production Growth Rate (2020-2025)
9.7.2 China Enasidenib Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bristol Myers Squibb
10.1.1 Bristol Myers Squibb Basic Information
10.1.2 Bristol Myers Squibb Enasidenib Drugs Product Overview
10.1.3 Bristol Myers Squibb Enasidenib Drugs Product Market Performance
10.1.4 Bristol Myers Squibb Business Overview
10.1.5 Bristol Myers Squibb SWOT Analysis
10.1.6 Bristol Myers Squibb Recent Developments
11 ENASIDENIB DRUGS MARKET FORECAST BY REGION
11.1 Global Enasidenib Drugs Market Size Forecast
11.2 Global Enasidenib Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Enasidenib Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Enasidenib Drugs Market Size Forecast by Region
11.2.4 South America Enasidenib Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Enasidenib Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Enasidenib Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Enasidenib Drugs by Type (2026-2035)
12.1.2 Global Enasidenib Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Enasidenib Drugs by Type (2026-2035)
12.2 Global Enasidenib Drugs Market Forecast by Application (2026-2035)
12.2.1 Global Enasidenib Drugs Sales (K MT) Forecast by Application
12.2.2 Global Enasidenib Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Enasidenib Drugs Market Size by Type (M USD)
Table 4. Global Enasidenib Drugs Market Size by Application
Table 5. Enasidenib Drugs Market Size Comparison by Region (M USD)
Table 6. Global Enasidenib Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Enasidenib Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Enasidenib Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Enasidenib Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enasidenib Drugs as of 2025)
Table 11. Global Market Enasidenib Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Enasidenib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Enasidenib Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Enasidenib Drugs Sales by Type (K MT)
Table 27. Global Enasidenib Drugs Market Size by Type (M USD)
Table 28. Global Enasidenib Drugs Sales (K MT) by Type (2020-2025)
Table 29. Global Enasidenib Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Enasidenib Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Enasidenib Drugs Market Share by Type (2020-2025)
Table 32. Global Enasidenib Drugs Price (USD/KG) by Type (2020-2025)
Table 33. Global Enasidenib Drugs Sales (K MT) by Application
Table 34. Global Enasidenib Drugs Market Size by Application
Table 35. Global Enasidenib Drugs Sales by Application (2020-2025) & (K MT)
Table 36. Global Enasidenib Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Enasidenib Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Enasidenib Drugs Market Share by Application (2020-2025)
Table 39. Global Enasidenib Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Enasidenib Drugs Sales by Region (2020-2025) & (K MT)
Table 41. Global Enasidenib Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Enasidenib Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Enasidenib Drugs Market Size by Region (2020-2025)
Table 44. North America Enasidenib Drugs Sales by Country (2020-2025) & (K MT)
Table 45. North America Enasidenib Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Enasidenib Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Europe Enasidenib Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Enasidenib Drugs Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Enasidenib Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Enasidenib Drugs Sales by Country (2020-2025) & (K MT)
Table 51. South America Enasidenib Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Enasidenib Drugs Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Enasidenib Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Enasidenib Drugs Production (K MT) by Region(2020-2025)
Table 55. Global Enasidenib Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Enasidenib Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bristol Myers Squibb Basic Information
Table 63. Bristol Myers Squibb Enasidenib Drugs Product Overview
Table 64. Bristol Myers Squibb Enasidenib Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bristol Myers Squibb Business Overview
Table 66. Bristol Myers Squibb SWOT Analysis
Table 67. Bristol Myers Squibb Recent Developments
Table 68. Global Enasidenib Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 69. Global Enasidenib Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 70. North America Enasidenib Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 71. North America Enasidenib Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 72. Europe Enasidenib Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 73. Europe Enasidenib Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 74. Asia Pacific Enasidenib Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 75. Asia Pacific Enasidenib Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 76. South America Enasidenib Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 77. South America Enasidenib Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 78. Middle East and Africa Enasidenib Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 79. Middle East and Africa Enasidenib Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 80. Global Enasidenib Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 81. Global Enasidenib Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 82. Global Enasidenib Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 83. Global Enasidenib Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 84. Global Enasidenib Drugs Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Enasidenib Drugs Market Size by Type (M USD)
Table 4. Global Enasidenib Drugs Market Size by Application
Table 5. Enasidenib Drugs Market Size Comparison by Region (M USD)
Table 6. Global Enasidenib Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Enasidenib Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Enasidenib Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Enasidenib Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enasidenib Drugs as of 2025)
Table 11. Global Market Enasidenib Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Enasidenib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Enasidenib Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Enasidenib Drugs Sales by Type (K MT)
Table 27. Global Enasidenib Drugs Market Size by Type (M USD)
Table 28. Global Enasidenib Drugs Sales (K MT) by Type (2020-2025)
Table 29. Global Enasidenib Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Enasidenib Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Enasidenib Drugs Market Share by Type (2020-2025)
Table 32. Global Enasidenib Drugs Price (USD/KG) by Type (2020-2025)
Table 33. Global Enasidenib Drugs Sales (K MT) by Application
Table 34. Global Enasidenib Drugs Market Size by Application
Table 35. Global Enasidenib Drugs Sales by Application (2020-2025) & (K MT)
Table 36. Global Enasidenib Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Enasidenib Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Enasidenib Drugs Market Share by Application (2020-2025)
Table 39. Global Enasidenib Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Enasidenib Drugs Sales by Region (2020-2025) & (K MT)
Table 41. Global Enasidenib Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Enasidenib Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Enasidenib Drugs Market Size by Region (2020-2025)
Table 44. North America Enasidenib Drugs Sales by Country (2020-2025) & (K MT)
Table 45. North America Enasidenib Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Enasidenib Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Europe Enasidenib Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Enasidenib Drugs Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Enasidenib Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Enasidenib Drugs Sales by Country (2020-2025) & (K MT)
Table 51. South America Enasidenib Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Enasidenib Drugs Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Enasidenib Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Enasidenib Drugs Production (K MT) by Region(2020-2025)
Table 55. Global Enasidenib Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Enasidenib Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Enasidenib Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bristol Myers Squibb Basic Information
Table 63. Bristol Myers Squibb Enasidenib Drugs Product Overview
Table 64. Bristol Myers Squibb Enasidenib Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bristol Myers Squibb Business Overview
Table 66. Bristol Myers Squibb SWOT Analysis
Table 67. Bristol Myers Squibb Recent Developments
Table 68. Global Enasidenib Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 69. Global Enasidenib Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 70. North America Enasidenib Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 71. North America Enasidenib Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 72. Europe Enasidenib Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 73. Europe Enasidenib Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 74. Asia Pacific Enasidenib Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 75. Asia Pacific Enasidenib Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 76. South America Enasidenib Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 77. South America Enasidenib Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 78. Middle East and Africa Enasidenib Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 79. Middle East and Africa Enasidenib Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 80. Global Enasidenib Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 81. Global Enasidenib Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 82. Global Enasidenib Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 83. Global Enasidenib Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 84. Global Enasidenib Drugs Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Enasidenib Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Enasidenib Drugs Market Size (M USD), 2025-2035
Figure 5. Global Enasidenib Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Enasidenib Drugs Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Enasidenib Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Enasidenib Drugs Product Life Cycle
Figure 13. Enasidenib Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Enasidenib Drugs Revenue Share by Manufacturers in 2025
Figure 15. Enasidenib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Enasidenib Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Enasidenib Drugs Revenue in 2025
Figure 18. Industry Chain Map of Enasidenib Drugs
Figure 19. Global Enasidenib Drugs Market PEST Analysis
Figure 20. Global Enasidenib Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Enasidenib Drugs Market Share by Type
Figure 27. Sales Market Share of Enasidenib Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Enasidenib Drugs by Type in 2025
Figure 29. Market Share of Enasidenib Drugs by Type (2020-2025)
Figure 30. Market Share of Enasidenib Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Enasidenib Drugs Market Share by Application
Figure 33. Global Enasidenib Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Enasidenib Drugs Sales Market Share by Application in 2025
Figure 35. Global Enasidenib Drugs Market Share by Application (2020-2025)
Figure 36. Global Enasidenib Drugs Market Share by Application in 2025
Figure 37. Global Enasidenib Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Enasidenib Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Enasidenib Drugs Market Size by Region (2020-2025)
Figure 40. North America Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Enasidenib Drugs Sales Market Share by Country in 2024
Figure 43. North America Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Enasidenib Drugs Market Size by Country in 2024
Figure 45. U.S. Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Enasidenib Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Enasidenib Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Enasidenib Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Enasidenib Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Enasidenib Drugs Sales Market Share by Country in 2024
Figure 53. Europe Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Enasidenib Drugs Market Size by Country in 2024
Figure 55. Germany Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Enasidenib Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Enasidenib Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Enasidenib Drugs Market Size by Region in 2024
Figure 68. China Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Enasidenib Drugs Sales and Growth Rate (K MT)
Figure 79. South America Enasidenib Drugs Sales Market Share by Country in 2024
Figure 80. South America Enasidenib Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Enasidenib Drugs Market Size by Country in 2024
Figure 82. Brazil Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Enasidenib Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Enasidenib Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Enasidenib Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Enasidenib Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Enasidenib Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Enasidenib Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Enasidenib Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Enasidenib Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Enasidenib Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Enasidenib Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Enasidenib Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Enasidenib Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Enasidenib Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Enasidenib Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Enasidenib Drugs Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Enasidenib Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Enasidenib Drugs Market Size (M USD), 2025-2035
Figure 5. Global Enasidenib Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Enasidenib Drugs Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Enasidenib Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Enasidenib Drugs Product Life Cycle
Figure 13. Enasidenib Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Enasidenib Drugs Revenue Share by Manufacturers in 2025
Figure 15. Enasidenib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Enasidenib Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Enasidenib Drugs Revenue in 2025
Figure 18. Industry Chain Map of Enasidenib Drugs
Figure 19. Global Enasidenib Drugs Market PEST Analysis
Figure 20. Global Enasidenib Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Enasidenib Drugs Market Share by Type
Figure 27. Sales Market Share of Enasidenib Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Enasidenib Drugs by Type in 2025
Figure 29. Market Share of Enasidenib Drugs by Type (2020-2025)
Figure 30. Market Share of Enasidenib Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Enasidenib Drugs Market Share by Application
Figure 33. Global Enasidenib Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Enasidenib Drugs Sales Market Share by Application in 2025
Figure 35. Global Enasidenib Drugs Market Share by Application (2020-2025)
Figure 36. Global Enasidenib Drugs Market Share by Application in 2025
Figure 37. Global Enasidenib Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Enasidenib Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Enasidenib Drugs Market Size by Region (2020-2025)
Figure 40. North America Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Enasidenib Drugs Sales Market Share by Country in 2024
Figure 43. North America Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Enasidenib Drugs Market Size by Country in 2024
Figure 45. U.S. Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Enasidenib Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Enasidenib Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Enasidenib Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Enasidenib Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Enasidenib Drugs Sales Market Share by Country in 2024
Figure 53. Europe Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Enasidenib Drugs Market Size by Country in 2024
Figure 55. Germany Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Enasidenib Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Enasidenib Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Enasidenib Drugs Market Size by Region in 2024
Figure 68. China Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Enasidenib Drugs Sales and Growth Rate (K MT)
Figure 79. South America Enasidenib Drugs Sales Market Share by Country in 2024
Figure 80. South America Enasidenib Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Enasidenib Drugs Market Size by Country in 2024
Figure 82. Brazil Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Enasidenib Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Enasidenib Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Enasidenib Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Enasidenib Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Enasidenib Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Enasidenib Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Enasidenib Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Enasidenib Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Enasidenib Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Enasidenib Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Enasidenib Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Enasidenib Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Enasidenib Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Enasidenib Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Enasidenib Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Enasidenib Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Enasidenib Drugs Market Share Forecast by Application (2026-2035)
